Revolutionizing brain tumor treatment: the rise of AI in neuro-oncology. A new review article in npj Precision Oncology summarizes the current state of knowledge about the role of artificial intelligence (AI) in the diagnosis, treatment, and prognosis of brain tumors. Read: https://lnkd.in/eQGXFygh #sciencesdelavie #biotechnology #biotechnology #innovation #innovations #research #sciences #medicaments #research #drugresearch #laboratories #labs #chemistry #chemistry #biology #biologie #biopharma #rna #rnatherapeutics #arn #wewillwin
Groupe UIG’s Post
More Relevant Posts
-
Revolutionizing brain tumor treatment: the rise of AI in neuro-oncology. A new review article in npj Precision Oncology summarizes the current state of knowledge about the role of artificial intelligence (AI) in the diagnosis, treatment, and prognosis of brain tumors. Read: https://lnkd.in/e2hPkHsx #sciencesdelavie #biotechnology #biotechnology #innovation #innovations #research #sciences #medicaments #research #drugresearch #laboratories #labs #chemistry #chemistry #biology #biologie #biopharma #rna #rnatherapeutics #arn #wewillwin
To view or add a comment, sign in
-
SLIDEVIEW™ VS200 Slide Scanner Your Tool to Advanced Research Discoveries! In the dynamic world of scientific research, the excellence and precision is essential. Today I want to present you SLIDEVIEW™ VS200 Slide Scanner: ☑️ Scan 210 slides in a single setup with the 35 slide trays. ☑️ Dive into diverse research fields, whether it's Brain Research, Drug Discovery, Cancer and Stem Cell Research, or Pathology. VS200 Scanner is designed to meet your needs. ☑️ Experience the flexibility of five Observation Methods in one system: - Brightfield - Darkfield - Fluorescence - Phase contrast - Polarization This integration ensures that you have the right tools to observe and analyze your samples from every perspective. For more information or to discuss how the VS200 can benefit your specific research needs, feel free to contact me directly or visit our website: https://lnkd.in/eGWs-BM8 #ResearchInnovation #ScientificDiscovery #SlideScanner #VS200 #BrainResearch #DrugDiscovery #CancerResearch #Pathology #StemCellResearch #microscopy #technology #knowhow #pathology #cytology #olympus #evident #lifescience #education #evidentscientific #cellculture #organoids #research #science #solution #imaging
To view or add a comment, sign in
-
📢 Call for Papers: Biology of Brain Tumors: State of the Art and Future Directions 🌐 🚀 About the Special Issue: We aspire to assemble a comprehensive collection of research articles and reviews that shed light on the biological underpinnings governing the initiation, growth, and diversity of brain tumors. 🗓️ Submission Deadline: 31 July 2024 🔗 Learn More: https://lnkd.in/g8B5-vZe 🎈Be part of this innovative journey! #BrainTumors #HeterogeneousDiseases #MolecularBasis #CancerGenetics #Biomarker #immunotherapy
To view or add a comment, sign in
-
Did you miss the webinar "Hypoxia in the Tumor Immune Microenvironment (TIME)"? Watch the recording here: https://lnkd.in/dkezKiWc Prof. Zaver M. Bhujwalla, at Johns Hopkins Medicine, reviews in vivo (e.g. PET/MR) and cellular and molecular (e.g. MRI/NMR spectroscopy) preclinical studies that provide new insights into varied tumor profiles/types and the underlying interplay in PD-L1 status, hypoxia, and fibroblasts in the tumor microenvironment. Such insights pave the way for improved therapies. #NMR #MRI #Imaging #PreclinicalImaging #Hypoxia #Oncology
To view or add a comment, sign in
-
Current trends and innovations in 3D organoids 🧬 Explore the future of 3D organoids in research and drug development with Labiotech.eu's in-depth report, sponsored by Sartorius 🌟 Learn how these advanced cell models are reshaping oncology, neuroscience, and immunology by providing more accurate human tissue simulations, and advancing personalized medicine. Download it here: https://lnkd.in/e9ZAVUyy #organoids #researchtrends #cellmodels #drugdevelopment
To view or add a comment, sign in
-
Don't hesitate to apply for the PhD subjects @UMR5280_ISA: · Characterisation and in vitro validation of biopolymers for the treatment of iron overload (contact agnes.hagege@univ-lyon1.fr ) · Structural and functional investigation of a molecular regulator involved in bacterial silver resistance using NMR (contacts maggy.hologne@univ-lyon1.fr; olivier.walker@univ-lyon1.fr ) · Contribute to the development and optimization of a signal processing and AI algorithm for microwave imaging in the early detection of breast cancer (latifa.bouchet@univ-lyon1.fr )
To view or add a comment, sign in
-
Are you a researcher involved in PET tracer development, cancer biology and therapeutics, or a nuclear #imaging specialist? Tune in for the free webinar "Hypoxia in the Tumor Immune Microenvironment (TIME)" on July 11, at 4 PM CEST: https://lnkd.in/d2ymrFZs Prof. Zaver M. Bhujwalla, at Johns Hopkins Medicine, will review in vivo (e.g. PET/MR) and cellular and molecular (e.g. MRI/NMR spectroscopy) preclinical studies that provide new insights into varied tumor profiles/types and the underlying interplay in PD-L1 status, hypoxia, and fibroblasts in the tumor microenvironment. Such insights pave the way for improved therapies. #NMR #MRI #PreclinicalImaging #Hypoxia #Oncology
Free Webinar "Hypoxia in the Tumor Immune Microenvironment (TIME)": Thursday, 11 July 2024, 16:00 CEST | 10:00 EDT
To view or add a comment, sign in
-
Are you a researcher involved in PET tracer development, cancer biology and therapeutics, or a nuclear #imaging specialist? Tune in for the free webinar "Hypoxia in the Tumor Immune Microenvironment (TIME)" on July 11, at 4 PM CEST: https://lnkd.in/diPbuZYc Prof. Zaver M. Bhujwalla, at Johns Hopkins Medicine, will review in vivo (e.g. PET/MR) and cellular and molecular (e.g. MRI/NMR spectroscopy) preclinical studies that provide new insights into varied tumor profiles/types and the underlying interplay in PD-L1 status, hypoxia, and fibroblasts in the tumor microenvironment. Such insights pave the way for improved therapies. #NMR #MRI #PreclinicalImaging #Hypoxia #Oncology
Free Webinar "Hypoxia in the Tumor Immune Microenvironment (TIME)": Thursday, 11 July 2024, 16:00 CEST | 10:00 EDT
To view or add a comment, sign in
-
Brian Weitzner put together an excellent overview of our protein design capabilities and a preview of some of the work we've been grinding on for the last couple years. If you're at #PWMC24 make sure to check out his presentation
🎤 At #PMWC24 today Brian Weitzner, Outpace Bio's head of computational & structural biology, will give an engaging talk on our latest efforts to create cell therapies for solid tumors with curative potential using our powerful AI-powered protein design platform. Don't miss it! Additional details below. Track: 1 Session: AI-enabled Approaches in Cell Therapy Time: 2:45 p PT Location: Santa Clara Convention Center #PMWC24 #AI #ProteinDesign #CancerResearch #CellTherapy #CARTcells #TCRtherapy #MedicalInnovation #Oncology #CancerTherapy #biotechnology
To view or add a comment, sign in
-
🔍 New Publication Alert! 🔬 "Exploring ncRNA-mediated regulation of EGFR signaling in glioblastoma: From mechanisms to therapeutics" – a significant stride towards understanding and combating the most aggressive brain tumor, glioblastoma. Published in 'Life Sciences,' our latest research delves into the intricate network of non-coding RNAs and their crucial role in the EGFR signaling pathway. The findings open up potential avenues for targeted therapeutic strategies, highlighting the importance of ncRNAs as biomarkers and therapeutic targets in glioblastoma. ✨ A big congratulations to all co-authors for their dedication and ground breaking work. Asif Ahmad Bhat , Kamal Dua , sachin singh, Goyal Ahsas 👉 For a deep dive into our research, the article is accessible [https://lnkd.in/g2zJJk-e]. #Glioblastoma #CancerResearch #MolecularBiology #ncRNA #EGFR #LifeSciences #Research #Innovation #Healthcare #SciencePublication
To view or add a comment, sign in
3,387 followers